Concepedia

Russell Z. Szmulewitz

RZ

68

Publications

5.2K

Citations

33

H-Index

2001

Active since

Affiliations

University of Chicago(Current)

Memorial Sloan Kettering Cancer Center

Cornell University

University of Tübingen

Pfizer (United States)

Russell Z. Szmulewitz is an author at University of Chicago specializing in medicine, oncology, and urology.

ORCID

Top concepts

Publications per year

2001–2024

68

Publications

68

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.1K citations · Full text

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study

Andrew J. Armstrong, Susan Halabi, Jun Luo et al. · Journal of Clinical Oncology · 2019 · 354 citations · Full text

Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer

Andrew J. Armstrong, Arun Azad, Taro Iguchi et al. · Journal of Clinical Oncology · 2022 · 279 citations · Full text

Glucocorticoid Receptor Activity Contributes to Resistance to Androgen-Targeted Therapy in Prostate Cancer

Masis Isikbay, Kristen Otto, Steven Kregel et al. · Hormones and Cancer · 2014 · 274 citations · Full text

, , +6

A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

Himisha Beltran, Clara Oromendia, Daniel C. Danila et al. · Clinical Cancer Research · 2018 · 268 citations · Full text

Rows per page

1–5 of 68